{
  "name": "Vertex Pharmaceuticals",
  "slug": "vertex-pharmaceuticals",
  "ticker": "VRTX",
  "fetched_at": "2025-08-30T12:19:36.142918+00:00",
  "news": [
    {
      "title": "Visualizing Vertex Pharmaceuticals Incorporated stock with heatmaps - July 2025 Pullbacks & High Accuracy Investment Signals - Newser",
      "link": "https://news.google.com/rss/articles/CBMiowFBVV95cUxON01kejc5Mm00bHpMcTNIZG5HWGVHenc3Y0NLSVZxbDE1cHBsZTlRRTQzMW1pbEg2REIwX0EzZlU5dDlPcmt1WnlWX0VidzYzNXI5amFYYVB0MWJGbG9UMHQzVkN3N3M5dTdxbm5USmhzazNGT1hXZlVUUl9UckVkSTV2NXdqNUF0ZWpuZG1KS3MyTHl2UDVBcWNsbXVlUE82N0hr?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiowFBVV95cUxON01kejc5Mm00bHpMcTNIZG5HWGVHenc3Y0NLSVZxbDE1cHBsZTlRRTQzMW1pbEg2REIwX0EzZlU5dDlPcmt1WnlWX0VidzYzNXI5amFYYVB0MWJGbG9UMHQzVkN3N3M5dTdxbm5USmhzazNGT1hXZlVUUl9UckVkSTV2NXdqNUF0ZWpuZG1KS3MyTHl2UDVBcWNsbXVlUE82N0hr?oc=5\" target=\"_blank\">Visualizing Vertex Pharmaceuticals Incorporated stock with heatmaps - July 2025 Pullbacks & High Accuracy Investment Signals</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Newser</font>",
      "published": "2025-08-30T04:54:48+00:00",
      "source": "Newser"
    },
    {
      "title": "Stock Analysis | Vertex Pharmaceuticals Outlook - Mixed Signals and a Weak Technical Profile - AInvest",
      "link": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOTW1SWkdpTzZzVER1eDBqZHF0MHZ5QzR5aHB4TlZ5UHVxUlNfTkFMSGtHMU9FY09EWk9NWHFVWDkycHhoLTNwQTh6aDRiV09zSlZhcW5FS1ZIUUxKQ1IyVlJUZ25qXy1YdGZHdl91cXhPVlZaQi11cEV5VDdqRlZ5TXdDS3FsZnA1Wlh1Smt0VzJBYkdIRXI5TmN3SGctcUk2YTJjWThkdENseG02cUowa3VhcjdjbVJq?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiuAFBVV95cUxOTW1SWkdpTzZzVER1eDBqZHF0MHZ5QzR5aHB4TlZ5UHVxUlNfTkFMSGtHMU9FY09EWk9NWHFVWDkycHhoLTNwQTh6aDRiV09zSlZhcW5FS1ZIUUxKQ1IyVlJUZ25qXy1YdGZHdl91cXhPVlZaQi11cEV5VDdqRlZ5TXdDS3FsZnA1Wlh1Smt0VzJBYkdIRXI5TmN3SGctcUk2YTJjWThkdENseG02cUowa3VhcjdjbVJq?oc=5\" target=\"_blank\">Stock Analysis | Vertex Pharmaceuticals Outlook - Mixed Signals and a Weak Technical Profile</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AInvest</font>",
      "published": "2025-08-30T03:28:45+00:00",
      "source": "AInvest"
    },
    {
      "title": "Meet the 2025 Vertex Science Leaders Scholarship recipients - Vertex Pharmaceuticals",
      "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxOTXFmVmwtdVAyTUY5QkFBSExaYjh0WXlGeFZrQWYzZDlBWnFoY0dCR0NXNVI4d1BXbmpZUF90SUdQVGxTN3JUOVNEVEZmYWgyb0lMc1d6NHBpR2J1dmd6a3VKSGRlVGprVGZ0Q2FITnRCOXZTMEZwWXRRTVY1R1EzeFFNWUpodUlidzJGYUd3?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxOTXFmVmwtdVAyTUY5QkFBSExaYjh0WXlGeFZrQWYzZDlBWnFoY0dCR0NXNVI4d1BXbmpZUF90SUdQVGxTN3JUOVNEVEZmYWgyb0lMc1d6NHBpR2J1dmd6a3VKSGRlVGprVGZ0Q2FITnRCOXZTMEZwWXRRTVY1R1EzeFFNWUpodUlidzJGYUd3?oc=5\" target=\"_blank\">Meet the 2025 Vertex Science Leaders Scholarship recipients</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Vertex Pharmaceuticals</font>",
      "published": "2025-08-25T13:08:07+00:00",
      "source": "Vertex Pharmaceuticals"
    },
    {
      "title": "Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMingFBVV95cUxPU01uOUZzYnZCb3BWdklCTVJNNk1RcjdoeWN4Z19sdjltdmdKTVZfYlZLNEpYSzNMSXpEMlE3MEY2YUdwSEhGdVJ4VndRSVZrSUQ5WnNKWTZ2U1Y0LVJNQU9IejJJVWtSd0hRM3JBYVVsMzl1azlXdUtELXJmNmdMWlVJM2ZqRjZOQUVRQjdzMmM1SkVfdGUwbWlsSmU4UQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMingFBVV95cUxPU01uOUZzYnZCb3BWdklCTVJNNk1RcjdoeWN4Z19sdjltdmdKTVZfYlZLNEpYSzNMSXpEMlE3MEY2YUdwSEhGdVJ4VndRSVZrSUQ5WnNKWTZ2U1Y0LVJNQU9IejJJVWtSd0hRM3JBYVVsMzl1azlXdUtELXJmNmdMWlVJM2ZqRjZOQUVRQjdzMmM1SkVfdGUwbWlsSmU4UQ?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-27T13:00:04+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex Pharmaceutical Stock Dives as Firm to Stop Developing Acute Pain Drug - Investopedia",
      "link": "https://news.google.com/rss/articles/CBMitAFBVV95cUxPSm1iMzM5VjEteHhaVHNhempsaUUwVmJzc3NmSlpVRnhkeWRVWmhlR2d3b0RZMzhZdXdzT28wU0FtbUczSXNoUDZCMnJPZGk5ZERFYVh4Z2RmZ3ZzOUM3QTdwc0tQdDFWR092VjIwSllxNWdpTE1OUTRxcVVKMzR4aURwZmVkdENiWHBsVi1PcGJ2cy1ab0NpUHVoN2QwdFYzYldTMnNLc2lrUEV3bm1MSlVaTG0?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMitAFBVV95cUxPSm1iMzM5VjEteHhaVHNhempsaUUwVmJzc3NmSlpVRnhkeWRVWmhlR2d3b0RZMzhZdXdzT28wU0FtbUczSXNoUDZCMnJPZGk5ZERFYVh4Z2RmZ3ZzOUM3QTdwc0tQdDFWR092VjIwSllxNWdpTE1OUTRxcVVKMzR4aURwZmVkdENiWHBsVi1PcGJ2cy1ab0NpUHVoN2QwdFYzYldTMnNLc2lrUEV3bm1MSlVaTG0?oc=5\" target=\"_blank\">Vertex Pharmaceutical Stock Dives as Firm to Stop Developing Acute Pain Drug</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investopedia</font>",
      "published": "2025-08-05T07:00:00+00:00",
      "source": "Investopedia"
    },
    {
      "title": "Maze Therapeutics referred to federal marketing regulators over challenge brought by Vertex - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPZjdyaUNqT19CamJOMUJfX0FwM00tdW5BRjBKMjdwRWdQb1JVemxTYmp2cjFHdVhwT0V4OHh2SDFtTXNCelVHVWxnWlNNTUxCa2duYlJqODh5NmNKalpGWUg3LXZ2Y0YyNS1JYjZIWkNRVFpaNTBNYTl2b2ViNGxWLUdyU2xscFlLZ0p2RENFT1RCbWVkZE9ManJ5aERzYmVaWEtpNy1MVXFhX2hXbEFYMG1iMXZVWmhDdVBXakR0U0trdw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPZjdyaUNqT19CamJOMUJfX0FwM00tdW5BRjBKMjdwRWdQb1JVemxTYmp2cjFHdVhwT0V4OHh2SDFtTXNCelVHVWxnWlNNTUxCa2duYlJqODh5NmNKalpGWUg3LXZ2Y0YyNS1JYjZIWkNRVFpaNTBNYTl2b2ViNGxWLUdyU2xscFlLZ0p2RENFT1RCbWVkZE9ManJ5aERzYmVaWEtpNy1MVXFhX2hXbEFYMG1iMXZVWmhDdVBXakR0U0trdw?oc=5\" target=\"_blank\">Maze Therapeutics referred to federal marketing regulators over challenge brought by Vertex</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-08-28T14:49:42+00:00",
      "source": "Fierce Pharma"
    },
    {
      "title": "Vertex Pharmaceuticals: The Stock Hasn't Dropped Enough Yet (NASDAQ:VRTX) - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNeHYzalNfR1E1cWFrb0Y1SFYxMXQyNnJwV05BcGh3OWk2d21XYzBSYTAtbHZfT25tdFJZRU1uR1lsNXpoeGNENS1mMDZrdmVLRmVZMUZSWmZBOUM0dC1CUU9yOW1vV0J2VWdqbVN4eHotLW90NlF0U3E5TjFIaGVUYVkxakltamVrZjJPQlZ1Nk1PX2gyZUdCOEl3?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxNeHYzalNfR1E1cWFrb0Y1SFYxMXQyNnJwV05BcGh3OWk2d21XYzBSYTAtbHZfT25tdFJZRU1uR1lsNXpoeGNENS1mMDZrdmVLRmVZMUZSWmZBOUM0dC1CUU9yOW1vV0J2VWdqbVN4eHotLW90NlF0U3E5TjFIaGVUYVkxakltamVrZjJPQlZ1Nk1PX2gyZUdCOEl3?oc=5\" target=\"_blank\">Vertex Pharmaceuticals: The Stock Hasn't Dropped Enough Yet (NASDAQ:VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-08-12T07:00:00+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "Can Vertex Pharmaceuticals Incorporated recover in the next quarter - Market Movers & AI Driven Stock Reports - Newser",
      "link": "https://news.google.com/rss/articles/CBMiowFBVV95cUxOZVhrOFBUT2k4ZWIwNm5jTjN2aHNRSWtncEJZYzU1RFJfa0tESE1QYUQxS3ZvbGxldGwtY25NMEQzMkt0RzNVRGp4bWE2OExkdkE4OWlnX0xRUTJIU3NWa2U5NXBVcm0wam94djZ2OXEzNWxpTVhObXRiNkNfYzZlOFlPdEdjRmUwdnlDY1pjckFRX0YxRjJHNkVWdkkzTE0xVnY4?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiowFBVV95cUxOZVhrOFBUT2k4ZWIwNm5jTjN2aHNRSWtncEJZYzU1RFJfa0tESE1QYUQxS3ZvbGxldGwtY25NMEQzMkt0RzNVRGp4bWE2OExkdkE4OWlnX0xRUTJIU3NWa2U5NXBVcm0wam94djZ2OXEzNWxpTVhObXRiNkNfYzZlOFlPdEdjRmUwdnlDY1pjckFRX0YxRjJHNkVWdkkzTE0xVnY4?oc=5\" target=\"_blank\">Can Vertex Pharmaceuticals Incorporated recover in the next quarter - Market Movers & AI Driven Stock Reports</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Newser</font>",
      "published": "2025-08-29T23:03:24+00:00",
      "source": "Newser"
    }
  ],
  "product_launches": [
    {
      "title": "Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX) - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5\" target=\"_blank\">Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-22T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex Pharmaceuticals' Prescription Growth and Pipeline Strength Bolster Buy Rating - AInvest",
      "link": "https://news.google.com/rss/articles/CBMitAFBVV95cUxQWk9BQ3JxWFFQQXZ3SFJxS0xfSGx3cU9HWThzTmxUY29QTlJwbUpsS0pINUZhQld1NDd2aVMxRlNYbjZpc0NRbG1pZ1JwQngwMFpQUGxwMHczY0pBMmltMUlrU0ZodERHNEVQa1MtLVBaeENQZ3ZoTjQ5Q2VaTFphaElBRUtObXJwc21LOGRzRk9LcXJTRmNpQUk4Y2tobkp6U2xOOF9ubGdEZFBybnZRbEFzeXM?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMitAFBVV95cUxQWk9BQ3JxWFFQQXZ3SFJxS0xfSGx3cU9HWThzTmxUY29QTlJwbUpsS0pINUZhQld1NDd2aVMxRlNYbjZpc0NRbG1pZ1JwQngwMFpQUGxwMHczY0pBMmltMUlrU0ZodERHNEVQa1MtLVBaeENQZ3ZoTjQ5Q2VaTFphaElBRUtObXJwc21LOGRzRk9LcXJTRmNpQUk4Y2tobkp6U2xOOF9ubGdEZFBybnZRbEFzeXM?oc=5\" target=\"_blank\">Vertex Pharmaceuticals' Prescription Growth and Pipeline Strength Bolster Buy Rating</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AInvest</font>",
      "published": "2025-08-25T15:07:03+00:00",
      "source": "AInvest"
    },
    {
      "title": "Vertex tops estimates on cystic fibrosis treatment strength, new products - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5\" target=\"_blank\">Vertex tops estimates on cystic fibrosis treatment strength, new products</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-08-04T07:00:00+00:00",
      "source": "Reuters"
    },
    {
      "title": "Vertex Pharmaceuticals: Promising Growth with Successful Launch and Strong Pipeline - TipRanks",
      "link": "https://news.google.com/rss/articles/CBMixwFBVV95cUxQWEN0dzJBekJiaFJYMm9qbVN5Q3djdThMV0VTSlI2aDRDSDM2ZHhCOHI5N3BxTzRMcnVRVzNBM05Sc21acGdKcXRhM01XTkdNT1QyLVRpWmFiMkJKb1lOZkxzMlBnbHFWbzAzUXdPNTBncG9ReGlkLXBMaFNIc1NRSTV1UjRxcUFmQ0RiTl9RUjJFdU9jQ0V0Si0wdW9mQ01ITWo1WVhzbUhEV253dmh4LVI0TnJvZ3BCVWNfNFFDVXowc0xvdU8w?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMixwFBVV95cUxQWEN0dzJBekJiaFJYMm9qbVN5Q3djdThMV0VTSlI2aDRDSDM2ZHhCOHI5N3BxTzRMcnVRVzNBM05Sc21acGdKcXRhM01XTkdNT1QyLVRpWmFiMkJKb1lOZkxzMlBnbHFWbzAzUXdPNTBncG9ReGlkLXBMaFNIc1NRSTV1UjRxcUFmQ0RiTl9RUjJFdU9jQ0V0Si0wdW9mQ01ITWo1WVhzbUhEV253dmh4LVI0TnJvZ3BCVWNfNFFDVXowc0xvdU8w?oc=5\" target=\"_blank\">Vertex Pharmaceuticals: Promising Growth with Successful Launch and Strong Pipeline</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
      "published": "2025-08-18T07:00:00+00:00",
      "source": "TipRanks"
    },
    {
      "title": "(suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain - Vertex Pharmaceuticals Newsroom",
      "link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQNGhZSnljSUNJSGJ4SzNPVXdNeXNncWRyT1dUWVY2VDVxWDFhamJGQUtSWlhJLVVJMmhSQjROckJNemJGZVlkY3ZmR0ZmYXBiX1J1ZHExdk1ZOW1wTWp5T1ZWa283c2RkYjdkUlgwMEtNejlNb3NJbVZJZlpyVmNweWptQ3dWeDAtV0NfVEJXNG5RU1pTZFRUY01hOEd0SXdwMXFTdEpGTnJTMklMX2NRUnBwUGhndjcyWUJzc0pn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxQNGhZSnljSUNJSGJ4SzNPVXdNeXNncWRyT1dUWVY2VDVxWDFhamJGQUtSWlhJLVVJMmhSQjROckJNemJGZVlkY3ZmR0ZmYXBiX1J1ZHExdk1ZOW1wTWp5T1ZWa283c2RkYjdkUlgwMEtNejlNb3NJbVZJZlpyVmNweWptQ3dWeDAtV0NfVEJXNG5RU1pTZFRUY01hOEd0SXdwMXFTdEpGTnJTMklMX2NRUnBwUGhndjcyWUJzc0pn?oc=5\" target=\"_blank\">(suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Vertex Pharmaceuticals Newsroom</font>",
      "published": "2025-01-30T08:00:00+00:00",
      "source": "Vertex Pharmaceuticals Newsroom"
    }
  ],
  "stock": {
    "ticker": "VRTX",
    "currency": "USD",
    "latest": {
      "date": "2025-08-29",
      "close": 391.0199890136719
    },
    "history": [
      {
        "date": "2025-08-21",
        "close": 397.4599914550781
      },
      {
        "date": "2025-08-22",
        "close": 395.1199951171875
      },
      {
        "date": "2025-08-25",
        "close": 388.94000244140625
      },
      {
        "date": "2025-08-26",
        "close": 387.17999267578125
      },
      {
        "date": "2025-08-27",
        "close": 389.0799865722656
      },
      {
        "date": "2025-08-28",
        "close": 392.04998779296875
      },
      {
        "date": "2025-08-29",
        "close": 391.0199890136719
      }
    ],
    "name": "Vertex Pharmaceuticals Incorpor"
  }
}